Tuesday, August 13, 2013 12:30:12 PM
Just a matter of time for this last shred of credibility to fall away. There is no money from HSBC - that just isn't how international equity investments are made. It's just a penny stock feint, like all the others.
Question - if there was a Hong Kong investor who wanted to put money in this highly speculative revenueless biotech start-up, why would he be doing it through BGMO C-Corp with tons of liabilities? He would cut his own deal directly with the target on much better terms. HH adds zero to the opportunity and has defaulted on agreements. BGMO's deal with NWI would be over because in 8 months, BGMO hasn't done anything.
Of course, this is just pointing out the obvious -- since money isn't real. Papers were faux. NWI is made-up shell.
Everything I post is my personal opinion.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM